Know Cancer

or
forgot password


N/A
21 Years
N/A
Not Enrolling
Both
Lung Cancer

Thank you

Trial Information


Inclusion Criteria:



1. able to understand and speak English;

2. at least 21 years old;

3. active treatment for a diagnosis of non-small cell lung cancer;

4. Karnofsky score > 80;47 and 5) have a telephone by which they can be reached.

Exclusion Criteria:

1. current substance abuse other than tobacco;

2. active treatment for psychiatric disorders excluding depression, and/or use of
antipsychotic medications;

3. cognitive impairment;

4. current active anti-cancer treatment;

5. participation in mindfulness-based classes, guided imagery, yoga, or relaxation
therapy courses; and

6. diagnosis of small cell lung cancer. We excluded small cell lung cancer because of
its very different disease presentation and its associated very rapid disease
progression.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care

Outcome Measure:

Changes in health related quality of life (HRQOL)

Outcome Description:

HRQOL. HRQOL includes symptom (worry, dyspnea, insomnia, depressive symptoms), physical and social functioning, and general health parameters.

Outcome Time Frame:

Baseline to 10 weeks

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

CTSI grant

NCT ID:

NCT01565980

Start Date:

March 2012

Completion Date:

January 2013

Related Keywords:

  • Lung Cancer
  • Lung cancer
  • mindfulness therapy
  • active treatment (radiation and/or chemotherapy)
  • Lung Neoplasms

Name

Location

Michigan State UniversityEast Lansing, Michigan  48824
Allegiance HealthJackson, Michigan  49201